| Autor: |
High, Juliet, Enne, Virve I., Barber, Julie A., Brealey, David, Turner, David A., Horne, Robert, Peters, Mark, Dhesi, Zaneeta, Wagner, Adam P., Pandolfo, Alyssa M., Stirling, Sue, Russell, Charlotte, O’Grady, Justin, Swart, Ann Marie, Gant, Vanya, Livermore, David M. |
| Rok vydání: |
2021 |
| DOI: |
10.6084/m9.figshare.16767521 |
| Popis: |
Additional file 3: Table S1. Timeline for Trial Actions. *Later on day 1 and as soon as possible after decision to test for pneumonia. Further specimens from the same participant may be tested on the machine, within the 21-day trial period, only if clinically indicated and a sample has also been sent routinely to the microbiology laboratory. 1Every day until 14 days after randomisation or until clinical cure of pneumonia, whichever is first. Assessments only required on these days if in ICU/CCU and not cured of pneumonia. 2Which assessment is used depends on whether participant is a child or an adult. Clinical teams record these routinely and will know which should be used. 3Data collected may pre- and post-date the trial period, but will be collected from clinical records by hospital staff. 4Window for “day 21” phone call to occur is from days 20-24 post randomisation, discharged participants only. 5Record if relevant until 21 days after randomisation (even if pneumonia is cured sooner). |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
